Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

321 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis.
ASTEC/EN.5 Study Group; Blake P, Swart AM, Orton J, Kitchener H, Whelan T, Lukka H, Eisenhauer E, Bacon M, Tu D, Parmar MK, Amos C, Murray C, Qian W. ASTEC/EN.5 Study Group, et al. Among authors: parmar mk. Lancet. 2009 Jan 10;373(9658):137-46. doi: 10.1016/S0140-6736(08)61767-5. Epub 2008 Dec 16. Lancet. 2009. PMID: 19070891 Free PMC article. Review.
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.
START Trialists' Group; Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bentzen SM, Bliss JM, Brown J, Dewar JA, Dobbs HJ, Haviland JS, Hoskin PJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Morgan DA, Owen JR, Simmons S, Sumo G, Sydenham MA, Venables K, Yarnold JR. START Trialists' Group, et al. Lancet. 2008 Mar 29;371(9618):1098-107. doi: 10.1016/S0140-6736(08)60348-7. Epub 2008 Mar 19. Lancet. 2008. PMID: 18355913 Free PMC article. Clinical Trial.
High versus low dose cisplatin in epithelial ovarian cancer.
Ghersi D, Parmar MK, Guthrie D, Williams C. Ghersi D, et al. Among authors: parmar mk. Lancet. 1992 Sep 12;340(8820):678-9. doi: 10.1016/0140-6736(92)92221-z. Lancet. 1992. PMID: 1355247 No abstract available.
Chemotherapy for ovarian cancer.
Parmar MK, Sandercock J. Parmar MK, et al. N Engl J Med. 1996 May 9;334(19):1268-9; author reply 1270. doi: 10.1056/NEJM199605093341912. N Engl J Med. 1996. PMID: 8606729 Free article. No abstract available.
Assessing the malignant potential of ovarian inclusion cysts in postmenopausal women within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a prospective cohort study.
Sharma A, Gentry-Maharaj A, Burnell M, Fourkala EO, Campbell S, Amso N, Seif MW, Ryan A, Parmar M, Jacobs I, Menon U; UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Sharma A, et al. BJOG. 2012 Jan;119(2):207-19. doi: 10.1111/j.1471-0528.2011.03038.x. Epub 2011 Jul 15. BJOG. 2012. PMID: 21762355 Clinical Trial.
No socioeconomic inequalities in ovarian cancer survival within two randomised clinical trials.
Abdel-Rahman ME, Butler J, Sydes MR, Parmar MK, Gordon E, Harper P, Williams C, Crook A, Sandercock J, Swart AM, Rachet B, Coleman MP; ICON2 and ICON3 investigators. Abdel-Rahman ME, et al. Among authors: parmar mk. Br J Cancer. 2014 Jul 29;111(3):589-97. doi: 10.1038/bjc.2014.303. Epub 2014 Jun 10. Br J Cancer. 2014. PMID: 24918817 Free PMC article.
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.
Parmar MK, Ledermann JA, Colombo N, du Bois A, Delaloye JF, Kristensen GB, Wheeler S, Swart AM, Qian W, Torri V, Floriani I, Jayson G, Lamont A, Tropé C; ICON and AGO Collaborators. Parmar MK, et al. Lancet. 2003 Jun 21;361(9375):2099-106. doi: 10.1016/s0140-6736(03)13718-x. Lancet. 2003. PMID: 12826431 Clinical Trial.
321 results